Literature DB >> 19504109

Dynamic contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: evaluation in a rat rhabdomyosarcoma model.

F De Keyzer1, V Vandecaveye, H Thoeny, F Chen, Y Ni, G Marchal, R Hermans, S Nuyts, W Landuyt, H Bosmans.   

Abstract

We aimed to examine different intratumoral changes after single-dose and fractionated radiotherapy, using diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) MRI in a rat rhabdomyosarcoma model. Four WAG/Rij rats with rhabdomyosarcomas in the flanks received single-dose radiotherapy of 8 Gy, and four others underwent fractionated radiotherapy (five times 3 Gy). In rats receiving single-dose radiotherapy, a significant perfusion decrease was found in the first 2 days post-treatment, with slow recuperation afterwards. No substantial diffusion changes could be seen; tumor growth delay was 12 days. The rats undergoing fractionated radiotherapy showed a similar perfusion decrease early after the treatment. However, a very strong increase in apparent diffusion coefficient occurred in the first 10 days; growth delay was 18 days. DW-MRI and DCE-MRI can be used to show early tumoral changes induced by radiotherapy. Single-dose and fractionated radiotherapy induce an immediate perfusion effect, while the latter induces more intratumoral necrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504109     DOI: 10.1007/s00330-009-1451-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

1.  Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration.

Authors:  Harriet C Thoeny; Frederik De Keyzer; Feng Chen; Vincent Vandecaveye; Erik K Verbeken; Bisan Ahmed; Xihe Sun; Yicheng Ni; Hilde Bosmans; Robert Hermans; Allan van Oosterom; Guy Marchal; Willy Landuyt
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

2.  Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.

Authors:  L D Stegman; A Rehemtulla; D A Hamstra; D J Rice; S J Jonas; K L Stout; T L Chenevert; B D Ross
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

3.  Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy.

Authors:  Steven D Allen; Anwar R Padhani; Andrzej S Dzik-Jurasz; Robert Glynne-Jones
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

4.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

Authors:  William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

5.  Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.

Authors:  Harriet C Thoeny; Frederik De Keyzer; Vincent Vandecaveye; Feng Chen; Xihe Sun; Hilde Bosmans; Robert Hermans; Eric K Verbeken; Chris Boesch; Guy Marchal; Willy Landuyt; Yicheng Ni
Journal:  Radiology       Date:  2005-09-28       Impact factor: 11.105

6.  Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.

Authors:  Wim Ceelen; Peter Smeets; Walter Backes; Nancy Van Damme; Tom Boterberg; Pieter Demetter; Isabel Bouckenooghe; Marieke De Visschere; Marc Peeters; Piet Pattyn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-02-02       Impact factor: 7.038

7.  Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.

Authors:  Linda van de Bunt; Uulke A van der Heide; Martijn Ketelaars; Gerard A P de Kort; Ina M Jürgenliemk-Schulz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-22       Impact factor: 7.038

8.  Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging.

Authors:  K Hatano; Y Sekiya; H Araki; M Sakai; T Togawa; Y Narita; Y Akiyama; S Kimura; H Ito
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

9.  Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation.

Authors:  Hisataka Kobayashi; Koen Reijnders; Sean English; Alexander T Yordanov; Diane E Milenic; Anastasia L Sowers; Deborah Citrin; Murali C Krishna; Thomas A Waldmann; James B Mitchell; Martin W Brechbiel
Journal:  Clin Cancer Res       Date:  2004-11-15       Impact factor: 12.531

10.  Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.

Authors:  T L Chenevert; P E McKeever; B D Ross
Journal:  Clin Cancer Res       Date:  1997-09       Impact factor: 12.531

View more
  10 in total

1.  Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited.

Authors:  Mónica García-Barros; Tin Htwe Thin; Jerzy Maj; Carlos Cordon-Cardo; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Role of MR-DWI and MR-PWI in the radiotherapy of implanted pulmonary VX-2 carcinoma in rabbits.

Authors:  Qiang Zhang; Mingmin Zhang; Zhaoxin Liu; Baoqi Shi; Fuliang Qi; Haijiang Wang; Yuan Lv; Haijiao Jin; Weijing Zhang
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

3.  Feng Chen's work on translational and clinical imaging.

Authors:  Feng Chen
Journal:  World J Radiol       Date:  2011-04-28

Review 4.  Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques.

Authors:  Laura M Fayad; Michael A Jacobs; Xin Wang; John A Carrino; David A Bluemke
Journal:  Radiology       Date:  2012-11       Impact factor: 11.105

5.  Preliminary study of CT in combination with MRI perfusion imaging to assess hemodynamic changes during angiogenesis in a rabbit model of lung cancer.

Authors:  Qiang Zhang; Baoqi Shi; Zhaoxin Liu; Mingmin Zhang; Weijing Zhang
Journal:  Onco Targets Ther       Date:  2013-06-17       Impact factor: 4.147

6.  Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.

Authors:  Esther A Kleibeuker; Emmanouil Fokas; Philip D Allen; Veerle Kersemans; Arjan W Griffioen; John Beech; Jaehong H Im; Sean C Smart; Kitty C Castricum; Jaap van den Berg; Iris A Schulkens; Sally A Hill; Adrian L Harris; Ben J Slotman; Henk M Verheul; Ruth J Muschel; Victor L Thijssen
Journal:  Oncotarget       Date:  2016-11-22

Review 7.  Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?

Authors:  Ruben S A Goedegebuure; Leonie K de Klerk; Adam J Bass; Sarah Derks; Victor L J L Thijssen
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

8.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.

Authors:  Thomas Nielsen; Thomas Wittenborn; Michael R Horsman
Journal:  Pharmaceutics       Date:  2012-11-07       Impact factor: 6.321

9.  DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data.

Authors:  Juan E Ortuño; María J Ledesma-Carbayo; Rui V Simões; Ana P Candiota; Carles Arús; Andrés Santos
Journal:  BMC Bioinformatics       Date:  2013-11-04       Impact factor: 3.169

10.  Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI.

Authors:  Thomas Weikert; Ole Christopher Maas; Tanja Haas; Markus Klarhöfer; Jens Bremerich; Flavio Forrer; Alexander Walter Sauter; Gregor Sommer
Journal:  Contrast Media Mol Imaging       Date:  2019-11-11       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.